Korro Bio, Inc.KRROEarnings & Financial Report
Nasdaq
NextMar 18, 2026
KRRO Q3 2025 Key Financial Metrics
Revenue
$1.1M
Gross Profit
N/A
Operating Profit
$-19.2M
Net Profit
$-18.1M
Gross Margin
N/A
Operating Margin
-1764.9%
Net Margin
-1657.0%
YoY Growth
N/A
EPS
$-1.92
Financial Flow
Korro Bio, Inc. Q3 2025 Financial Summary
Korro Bio, Inc. reported revenue of $1.1M for Q3 2025, with a net profit of $-18.1M (-1657.0% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $1.1M |
|---|---|
| Net Profit | $-18.1M |
| Gross Margin | N/A |
| Operating Margin | -1764.9% |
| Report Period | Q3 2025 |
Korro Bio, Inc. Annual Revenue by Year
Korro Bio, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.3M).
| Year | Annual Revenue |
|---|---|
| 2024 | $2.3M |
| 2023 | $0 |
| 2022 | $0 |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $-214000 | $0 | $0 | $0 | $2.3M | $2.5M | $1.5M | $1.1M |
| YoY Growth | N/A | N/A | N/A | N/A | 1161.2% | N/A | N/A | N/A |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $221.7M | $198.0M | $249.6M | $243.5M | $226.2M | $202.2M | $180.4M | $161.6M |
| Liabilities | $51.8M | $46.6M | $51.5M | $63.9M | $65.8M | $63.3M | $65.3M | $62.5M |
| Equity | $169.9M | $151.4M | $198.1M | $179.6M | $160.4M | $139.0M | $115.1M | $99.0M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-39.9M | $-21.9M | $-14.6M | $-16.1M | $-7.5M | $-24.5M | $-19.2M | $-17.2M |